Bernd Richter

Title: Bernd Richter: Innovator in Medicinal Chemistry

Introduction

Bernd Richter is a notable inventor based in Bergisch Gladbach, Germany. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative patents. With a total of 4 patents, Richter's work has the potential to impact the development of new therapeutic agents.

Latest Patents

Richter's latest patents include the development of 8-substituted 2-aminotetralins. These new compounds can be synthesized from the corresponding aminotetralins or tetralones and are intended for use in medicaments. Another significant patent involves 1,3,4,5-tetrahydrobenz(c,d)indoles, which are novel compounds that exhibit an affinity for 5-hydroxytryptamine receptors. These compounds have the potential to play a crucial role in various therapeutic applications.

Career Highlights

Richter is currently associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His work at Bayer has allowed him to focus on the development of innovative medicinal compounds that address unmet medical needs.

Collaborations

Richter has collaborated with esteemed colleagues such as Thomas Glaser and Jorg Traber. These partnerships have fostered a collaborative environment that enhances the research and development of new medicinal products.

Conclusion

Bernd Richter's contributions to medicinal chemistry through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in therapeutic solutions.